The Synthetic & Rayon Textiles Export Promotion Council

Procedure and Criteria for submission and approval of applications for export of Diagnostic Kits and their components laboratory reagents

 

Circular No. ES/440/2020-21         4th March, 2021                                                                                                   

To: Members of the Council       

Sub: Procedure and Criteria for submission and approval of applications for export of Diagnostic Kits and their components laboratory reagents

Dear Member,

O/o DGFT has issued Trade Notice No. 45/2020-21 dated 2nd March, 2021 regarding the procedure and criteria for submission and approval of applications for export of Diagnostic Kits and their components laboratory reagents.

Your kind reference is invited to DGFT Notification No. 09 dated 10th June, 2020 restricting the export of Diagnostic Kits/Laboratory Reagents/Diagnostic Apparatus.

The quota for export of the following types of diagnostic kits was fixed for the period from December, 2020 to February, 2021 vide Trade Notice 39 dated 19th January, 2021. The applications received as per the Trade Notice were issued export licenses, and the quota has not been exhausted. The details of quantity remaining for allocation are as under:

S. No.

Item Description

Quantity (Nos)

1

RT-PCR Kits (COVID/Non-COVID) or its component elements (Probe Specific for Covid-19, Primers specific for Covid-19 Reverse Transcriptase Enzyme and Deoxy Nucleotide Triphosphate) exported as part of a kit or individually

10461487

2

RNA Extraction Kits or its component elements (Silicone Columns, Poly AdenylicAcide or Carrier RNA, Proteinase K, Magnatic Stands, Beads) exported as part of a kit or individually

22362999

3

VTM Kits or its component elements (15 ml Falcom Tube or Cryovials, Swabs sterile synthetic fibre swabs (Nylon, polyster, Rayon or Dacron) exported as part of a kit or individually

30405596

Export of Diagnostic kits and their components/laboratory reagents as per above mentioned leftover export quota is available and exporters are requested to apply for export license by filing applications online through DGFT’s ECOM system for Export authorizations (Non-SCOMET Restricted items) – Please refer to Trade Notice No. 50 dated 18.03.2019. There is no need to send any hard copy of the application via mail or post.

Exporters who have already filed an online application for export of these diagnostic kits after 1st February, 2020 need not apply again. However, they need to write a mail with the application file number and also submit the documents as described in this trade notice through email at export-dgft@nic.in mentioning the specific file number in the subject of the mail.

Online applications for export of “Diagnostic Kits (VTM/ RNA Extraction kits/ RT-PCR Kits) or their components /laboratory reagents” for the above quantities may be applied from 4th March to 9th March, 2021.

All the applications will be examined as per the Para 2.72 of Handbook of procedures.

Validity of the export license will be for 6 months only.

The following eligibility criteria will be applicable for consideration of applications:

  • Documentary proof of manufacturing “VTM/ RNA Extraction kits/ RT-PCR Kits

  • Only 1 application per IEC may be considered during this period.

The documents to be submitted may include the following:

  • Copy of Purchase order/Invoice

  • Copy of IEC

  • Undertaking duly signed by the authorized signatory in the company letter head to be submitted by the manufacturer certifying that as on date, all domestic commitments/orders have been fulfilled.

Please make a note of the following:

  • All the documents must be duly self-attested by the authorized person of the firm.

  • All the relevant documents as specified above must be submitted along with the application to verify the eligibility criteria.

  • Incomplete applications will not be considered for any allocation.

  • Any application received through email or submitted outside the timeline specified will not be considered.

Members may kindly make a note of the above. 

Thanking you,  

Yours faithfully,

S. BALARAJU 
EXECUTIVE DIRECTOR